Back to News
Market Impact: 0.05
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Source: zacks.com
Healthcare & Biotech
First Trust NYSE Arca Biotechnology ETF (FBT), a smart-beta ETF launched on June 19, 2006, provides broad exposure to the healthcare and biotechnology ETF category. The article contains no new performance, holdings, flow, or strategy information likely to affect markets.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- J&J's potential 'game-changer' drug — plus, what Microsoft's mass buyouts mean
- The excitement around Moderna’s cancer vaccine is cooling. Here’s why.
- Cramer: I asked some tech insiders what to buy. They surprisingly said this drug stock
- Genmab shares jump 13% on colorectal cancer drug trial results
- Moderna CEO Sees Cancer Vaccines Working Beyond Melanoma
- Bottoms Says Georgia Needs Pause on New Data Centers